168 related articles for article (PubMed ID: 10571844)
1. Acral erythema in children receiving high-dose methotrexate.
Millot F; Auriol F; Brecheteau P; Guilhot F
Pediatr Dermatol; 1999; 16(5):398-400. PubMed ID: 10571844
[TBL] [Abstract][Full Text] [Related]
2. Acral erythema with bullous formation: a side effect of chemotherapy in a child with acute lymphoblastic leukemia.
Aytaç S; Gümrük F; Cetin M; Tuncer M; Yetgin S
Turk J Pediatr; 2010; 52(2):211-4. PubMed ID: 20560263
[TBL] [Abstract][Full Text] [Related]
3. [Burgdorf's reaction (painful acral erythema) in patients with acute lymphoblastic leukemia following medium-dose methotrexate therapy].
Wysocki M; Nowaczyk-Michalak A; Pilecki O; Kurylak A; Balcar-Boroń A; Trybuś L
Wiad Lek; 1992 Jun; 45(11-12):462-4. PubMed ID: 1441532
[TBL] [Abstract][Full Text] [Related]
4. Acral erythema with oral methotrexate in a child.
Varela CR; McNamara J; Antaya RJ
Pediatr Dermatol; 2007; 24(5):541-6. PubMed ID: 17958806
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin in the treatment of severe methotrexate-induced acral erythema.
Tezer H; Kuskonmaz B; Kara A; Devrim I; Tuncer M; Cengiz AB; Yetgin S; Seçmeer G
J Pediatr Hematol Oncol; 2008 May; 30(5):391-3. PubMed ID: 18458576
[TBL] [Abstract][Full Text] [Related]
6. Hypersensitivity reaction to high-dose methotrexate and methotrexate-induced acral erythema in a child with acute lymphoblastic leukemia.
Akaihata M; Miyata K; Shimomura Y; Hori T; Okumura A
Int J Clin Pharmacol Ther; 2022 Jun; 60(6):264-268. PubMed ID: 35343432
[TBL] [Abstract][Full Text] [Related]
7. High-dose Methotrexate-induced Acral Erythema in Two Pediatric Patients With Acute Lymphoblastic Leukemia: A 17 Pediatric Case Series of Methotrexate-induced Acral Erythema.
Noguchi K; Nishimura R; Ikawa Y; Mase S; Fujiki T; Kuroda R; Araki R; Maeba H; Yachie A; Wada T
J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1259-e1261. PubMed ID: 34486565
[No Abstract] [Full Text] [Related]
8. Toxic epidermal necrolysis following combination of methotrexate and trimethoprim-sulfamethoxazole.
Yang CH; Yang LJ; Jaing TH; Chan HL
Int J Dermatol; 2000 Aug; 39(8):621-3. PubMed ID: 10971734
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous side effects of medium dose methotrexate in children with acute lymphoblastic leukaemia.
van den Bos C; Bierings MB; Bruin MC; Rademaker CM; van Haselen CW; Révész T
Med Pediatr Oncol; 2000 Apr; 34(4):278-80. PubMed ID: 10742071
[No Abstract] [Full Text] [Related]
10. Acral erythema caused by high-dose methotrexate therapy in patients with osteogenic sarcoma.
Postovsky S; Ben Arush MW
Pediatr Hematol Oncol; 2005 Mar; 22(2):167-73. PubMed ID: 15805003
[TBL] [Abstract][Full Text] [Related]
11. A single assessment of methotrexate levels at 42 hours permits safe administration and early discharge in children with lymphoblastic lymphoma and leukemia receiving high-dose methotrexate.
Totadri S; Srinivasan HN; Joseph LL; Boddu D; Mathew LG; John R
Pediatr Hematol Oncol; 2021 Aug; 38(5):434-443. PubMed ID: 33764242
[TBL] [Abstract][Full Text] [Related]
12. Clofarabine-induced acral erythema during the treatment of patients with myelodysplasia and acute leukemia: report of two cases.
Chiao N; Bumgardner A; Duvic M
Leuk Lymphoma; 2003 Aug; 44(8):1405-7. PubMed ID: 12952235
[TBL] [Abstract][Full Text] [Related]
13. Plasma homocysteine, methionine and S-adenosylhomocysteine levels following high-dose methotrexate treatment in pediatric patients with acute lymphoblastic leukemia or Burkitt lymphoma: association with hepatotoxicity.
Kubota M; Nakata R; Adachi S; Watanabe K; Heike T; Takeshita Y; Shima M
Leuk Lymphoma; 2014 Jul; 55(7):1591-5. PubMed ID: 24090503
[TBL] [Abstract][Full Text] [Related]
14. [6-mercaptopurine-related hand-foot syndrome in a four-year-old child].
Giacchero D; Monpoux F; Chiavérini C; Lacour JP
Ann Dermatol Venereol; 2008; 135(8-9):580-3. PubMed ID: 18789293
[TBL] [Abstract][Full Text] [Related]
15. Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia.
Csordas K; Hegyi M; Eipel OT; Muller J; Erdelyi DJ; Kovacs GT
Anticancer Drugs; 2013 Feb; 24(2):189-97. PubMed ID: 23187460
[TBL] [Abstract][Full Text] [Related]
16. [Accidental shortening time of high dose methotrexate infusion: case report and literature review].
Charfi R; Salouage I; Trabelsi S; Zarrouk M; Gaïes E; Jebabli N; Meddeb B; Lakhal M; Klouz A
Ann Biol Clin (Paris); 2013; 71(2):219-22. PubMed ID: 23587592
[TBL] [Abstract][Full Text] [Related]
17. Monitoring Of High-Dose Methotrexate (Mtx)-Related Toxicity and Mtx Levels in Children with Acute Lymphoblastic Leukemia: A Pilot-Study in Indonesia.
Sari NM; Rakhmilla LE; Bashari MH; Zazuli Z; Suryawan N; Susanah S; Reniarti L; Raspati H; Supriyadi E; Kaspers GJL; Idjradinata P
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2025-2031. PubMed ID: 34319023
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate-induced bullous acral erythema in a child.
Werchniak AE; Chaffee S; Dinulos JG
J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S93-5. PubMed ID: 15858519
[TBL] [Abstract][Full Text] [Related]
19. Bullous variant of acral erythema due to methotrexate.
Kuruvila S; Dalal M; Sivanesan B
Indian J Dermatol Venereol Leprol; 2006; 72(6):440-2. PubMed ID: 17179620
[TBL] [Abstract][Full Text] [Related]
20. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
